Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Help & FAQ
Home
Profiles
Research units
Core Facilities
Publications
Search by expertise, name or affiliation
Celecoxib with chemotherapy in colorectal cancer.
Charles D. Blanke
Knight Cancer Institute
Research output
:
Contribution to journal
›
Review article
›
peer-review
28
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Celecoxib with chemotherapy in colorectal cancer.'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Medicine & Life Sciences
Celecoxib
100%
Colorectal Neoplasms
62%
Drug Therapy
46%
Cyclooxygenase 2 Inhibitors
39%
Cyclooxygenase 2
35%
Sulindac
33%
Gastrointestinal Neoplasms
26%
Neoplasms
25%
Prostaglandins
21%
Adenomatous Polyposis Coli
13%
United States Food and Drug Administration
11%
Indomethacin
11%
Immunosuppression
10%
Arthritis
9%
Pharmaceutical Preparations
9%
Psychological Inhibition
9%
Anti-Inflammatory Agents
8%
Clinical Trials
7%
Neoplasm Metastasis
6%
Apoptosis
6%
Phenotype
6%
Cell Line
6%
Pain
6%
Enzymes
6%
Growth
5%
Mortality
5%
Therapeutics
5%
Incidence
5%